Title |
Drug-Induced Liver Injury Network (DILIN) Prospective Study
|
---|---|
Published in |
Drug Safety, November 2012
|
DOI | 10.2165/00002018-200932010-00005 |
Pubmed ID | |
Authors |
Robert J. Fontana, Paul B. Watkins, Herbert L. Bonkovsky, Naga Chalasani, Timothy Davern, Jose Serrano, James Rochon, the DILIN Study Group |
Abstract |
Drug-induced liver injury (DILI) is an uncommon adverse drug reaction of increasing importance to the medical community, pharmaceutical industry, regulatory agencies and the general public. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 33% |
United States | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 138 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Chile | 2 | 1% |
United States | 2 | 1% |
Sweden | 1 | <1% |
Spain | 1 | <1% |
United Kingdom | 1 | <1% |
Unknown | 131 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 22 | 16% |
Student > Ph. D. Student | 19 | 14% |
Student > Master | 14 | 10% |
Other | 11 | 8% |
Student > Bachelor | 11 | 8% |
Other | 31 | 22% |
Unknown | 30 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 46 | 33% |
Agricultural and Biological Sciences | 16 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 8% |
Biochemistry, Genetics and Molecular Biology | 7 | 5% |
Social Sciences | 3 | 2% |
Other | 14 | 10% |
Unknown | 41 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2023.
All research outputs
#1,544,936
of 25,373,627 outputs
Outputs from Drug Safety
#142
of 1,852 outputs
Outputs of similar age
#12,708
of 285,231 outputs
Outputs of similar age from Drug Safety
#43
of 812 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,231 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 812 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.